{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:34:22Z","timestamp":1793982862454,"version":"4.8.0"},"reference-count":60,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000971","name":"Amyotrophic Lateral Sclerosis Association","doi-asserted-by":"publisher","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}],"id":[{"id":"10.13039\/100000971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010969","name":"Alzheimer Nederland","doi-asserted-by":"publisher","award":["Memorabel grant no. 733050103"],"award-info":[{"award-number":["Memorabel grant no. 733050103"]}],"id":[{"id":"10.13039\/501100010969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010969","name":"Alzheimer Nederland","doi-asserted-by":"publisher","award":["Memorabel grant no. 7330550813"],"award-info":[{"award-number":["Memorabel grant no. 7330550813"]}],"id":[{"id":"10.13039\/501100010969","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Bluefield Project to Cure Frontotemporal Dementia","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]},{"name":"EU Joint Programme - Neurodegenerative Disease Research","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]},{"DOI":"10.13039\/501100010573","name":"Stichting Dioraphte","doi-asserted-by":"publisher","award":["1402 1300"],"award-info":[{"award-number":["1402 1300"]}],"id":[{"id":"10.13039\/501100010573","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 NS099631"],"award-info":[{"award-number":["R21 NS099631"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 NS110994"],"award-info":[{"award-number":["R21 NS110994"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["Memorabel grant no. 733050103"],"award-info":[{"award-number":["Memorabel grant no. 733050103"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["Memorabel grant no. 7330550813"],"award-info":[{"award-number":["Memorabel grant no. 7330550813"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:p>\n                    Since the discovery of the\n                    <jats:italic>C9orf72<\/jats:italic>\n                    repeat expansion as the most common genetic cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis, it has increasingly been associated with a wider spectrum of phenotypes, including other types of dementia, movement disorders, psychiatric symptoms and slowly progressive FTD. Prompt recognition of patients with\n                    <jats:italic>C9orf72<\/jats:italic>\n                    -associated diseases is essential in light of upcoming clinical trials. The striking clinical heterogeneity associated with\n                    <jats:italic>C9orf72<\/jats:italic>\n                    repeat expansions remains largely unexplained. In contrast to other repeat expansion disorders, evidence for an effect of repeat length on phenotype is inconclusive. Patients with\n                    <jats:italic>C9orf72<\/jats:italic>\n                    -associated diseases typically have very long repeat expansions, containing hundreds to thousands of GGGGCC-repeats, but smaller expansions might also have clinical significance. The exact threshold at which repeat expansions lead to neurodegeneration is unknown, and discordant cut-offs between laboratories pose a challenge for genetic counselling. Accurate and large-scale measurement of repeat expansions has been severely hindered by technical difficulties in sizing long expansions and by variable repeat lengths across and within tissues. Novel long-read sequencing approaches have produced promising results and open up avenues to further investigate this enthralling repeat expansion, elucidating whether its length, purity, and methylation pattern might modulate clinical features of\n                    <jats:italic>C9orf72<\/jats:italic>\n                    -related diseases.\n                  <\/jats:p>","DOI":"10.1136\/jnnp-2020-325377","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T13:25:55Z","timestamp":1610717155000},"page":"502-509","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":56,"title":["Unravelling the clinical spectrum and the role of repeat length in\n                    <i>C9ORF72<\/i>\n                    repeat expansions"],"prefix":"10.1136","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2570-8796","authenticated-orcid":false,"given":"Emma L.","family":"van der Ende","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jazmyne L.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianna","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1989-7527","authenticated-orcid":false,"given":"Harro","family":"Seelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3054-7053","authenticated-orcid":false,"given":"Marka","family":"van Blitterswijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6278-6844","authenticated-orcid":false,"given":"John C.","family":"Van Swieten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"2022011608400581000_92.5.502.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2011.09.011"},{"key":"2022011608400581000_92.5.502.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2011.09.010"},{"key":"2022011608400581000_92.5.502.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2013.01.011"},{"key":"2022011608400581000_92.5.502.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70043-1"},{"key":"2022011608400581000_92.5.502.5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/B978-0-444-63233-3.00009-9","article-title":"Repeat expansion diseases","volume":"147","author":"Paulson","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"2022011608400581000_92.5.502.6","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2014-102360"},{"key":"2022011608400581000_92.5.502.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2013.11.034"},{"key":"2022011608400581000_92.5.502.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70210-2"},{"key":"2022011608400581000_92.5.502.9","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22244"},{"key":"2022011608400581000_92.5.502.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0047-2"},{"key":"2022011608400581000_92.5.502.11","article-title":"Divergence, convergence, and therapeutic implications: a cell biology perspective of C9ORF72-ALS\/FTD","volume":"15","author":"Tang","year":"2020","journal-title":"Mol Neurodegener"},{"key":"2022011608400581000_92.5.502.12","doi-asserted-by":"crossref","first-page":"238.e25","DOI":"10.1016\/j.neurobiolaging.2019.04.012","article-title":"The role of C9orf72 in neurodegenerative disorders: a systematic review, an updated meta-analysis, and the creation of an online database","volume":"84","author":"Marogianni","year":"2019","journal-title":"Neurobiol Aging"},{"key":"2022011608400581000_92.5.502.13","doi-asserted-by":"crossref","first-page":"10.1212\/WNL.0000000000008359","DOI":"10.1212\/WNL.0000000000008359","article-title":"Prospective natural history study of C9orf72 ALS clinical characteristics and biomarkers","volume":"93","author":"Cammack","year":"2019","journal-title":"Neurology"},{"key":"2022011608400581000_92.5.502.14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/jamaneurol.2019.3924","article-title":"Survival and prognostic factors in C9orf72 repeat expansion carriers: a systematic review and meta-analysis","volume":"77","author":"Glasmacher","year":"2020","journal-title":"JAMA Neurol"},{"key":"2022011608400581000_92.5.502.15","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr355"},{"key":"2022011608400581000_92.5.502.16","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr179"},{"key":"2022011608400581000_92.5.502.17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jamaneurol.2013.6002","article-title":"Frontotemporal dementia associated with the C9orf72 mutation: a unique clinical profile","volume":"71","author":"Devenney","year":"2014","journal-title":"JAMA Neurol"},{"key":"2022011608400581000_92.5.502.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2012.12.019"},{"key":"2022011608400581000_92.5.502.19","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr361"},{"key":"2022011608400581000_92.5.502.20","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2011-301883"},{"key":"2022011608400581000_92.5.502.21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/13554794.2018.1428353","article-title":"Slowly progressive behavioral frontotemporal dementia with C9orf72 mutation. Case report and review of the literature","volume":"24","author":"Llamas-Velasco","year":"2018","journal-title":"Neurocase"},{"key":"2022011608400581000_92.5.502.22","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/2013.jamaneurol.537","article-title":"C9Orf72 hexanucleotide repeat expansions in clinical Alzheimer disease","volume":"70","author":"Harms","year":"2013","journal-title":"JAMA Neurol"},{"key":"2022011608400581000_92.5.502.23","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-012-1048-7"},{"key":"2022011608400581000_92.5.502.24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1113592"},{"key":"2022011608400581000_92.5.502.25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131817","article-title":"The phenotype of the C9orf72 expansion carriers according to revised criteria for bvFTD","volume":"10","author":"Solje","year":"2015","journal-title":"PLoS One"},{"key":"2022011608400581000_92.5.502.26","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jamaneurol.2013.6368","article-title":"Expanded C9orf72 hexanucleotide repeat in depressive pseudodementia","volume":"71","author":"Bieniek","year":"2014","journal-title":"JAMA Neurol"},{"key":"2022011608400581000_92.5.502.27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jagp.2015.04.007","article-title":"Frontotemporal dementia and psychiatric illness: emerging clinical and biological links in gene carriers","volume":"24","author":"Block","year":"2016","journal-title":"Am J Geriatr Psychiatry"},{"key":"2022011608400581000_92.5.502.28","doi-asserted-by":"crossref","first-page":"1510.e1","DOI":"10.1016\/j.neurobiolaging.2013.12.003","article-title":"Analysis of the hexanucleotide repeat expansion and founder haplotype at C9orf72 in an Irish psychosis case-control sample","volume":"35","author":"Fahey","year":"2014","journal-title":"Neurobiol Aging"},{"key":"2022011608400581000_92.5.502.29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/YPG.0000000000000118","article-title":"The C9orf72 expansion sizes in patients with psychosis: a population-based study on the Northern Finland birth cohort 1966","volume":"26","author":"Solje","year":"2016","journal-title":"Psychiatr Genet"},{"key":"2022011608400581000_92.5.502.30","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws004"},{"key":"2022011608400581000_92.5.502.31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.parkreldis.2020.09.019","article-title":"Isolated parkinsonism is an atypical presentation of GRN and C9orf72 gene mutations","volume":"80","author":"Carneiro","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"2022011608400581000_92.5.502.32","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00415-016-8021-7","article-title":"Atypical parkinsonism in C9orf72 expansions: a case report and systematic review of 45 cases from the literature","volume":"263","author":"Wilke","year":"2016","journal-title":"J Neurol"},{"key":"2022011608400581000_92.5.502.33","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws357"},{"key":"2022011608400581000_92.5.502.34","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182a2cc38"},{"key":"2022011608400581000_92.5.502.35","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/nan.12623","article-title":"Parkinsonism in C9orf72 expansion without co-existing Lewy body pathology; a case report and review of the literature","volume":"46","author":"Shivji","year":"2020","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2022011608400581000_92.5.502.36","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1212\/WNL.0000000000001012","article-title":"Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease","volume":"83","author":"Theuns","year":"2014","journal-title":"Neurology"},{"key":"2022011608400581000_92.5.502.37","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25838"},{"key":"2022011608400581000_92.5.502.38","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000061"},{"key":"2022011608400581000_92.5.502.39","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s10072-018-3268-7","article-title":"Clinical spectrum of C9orf72 expansion in a cohort of Huntington's disease phenocopies","volume":"39","author":"Martins","year":"2018","journal-title":"Neurol Sci"},{"key":"2022011608400581000_92.5.502.40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cll.2020.05.002","article-title":"Genetic testing for amyotrophic lateral sclerosis and frontotemporal dementia: impact on clinical management","volume":"40","author":"Roggenbuck","year":"2020","journal-title":"Clin Lab Med"},{"key":"2022011608400581000_92.5.502.41","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa018"},{"key":"2022011608400581000_92.5.502.42","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/21678421.2019.1588904","article-title":"The C9orf72 hexanucleotide repeat expansion presents a challenge for testing laboratories and genetic counseling","volume":"20","author":"Crook","year":"2019","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2022011608400581000_92.5.502.43","doi-asserted-by":"crossref","first-page":"546.e1","DOI":"10.1016\/j.neurobiolaging.2014.07.037","article-title":"Screening a UK amyotrophic lateral sclerosis cohort provides evidence of multiple origins of the C9orf72 expansion","volume":"36","author":"Fratta","year":"2015","journal-title":"Neurobiol Aging"},{"key":"2022011608400581000_92.5.502.44","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/mp.2015.159","article-title":"The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter","volume":"21","author":"Gijselinck","year":"2016","journal-title":"Mol Psychiatry"},{"key":"2022011608400581000_92.5.502.45","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1212\/WNL.0000000000004865","article-title":"Unaffected mosaic C9orf72 case: RNA foci, dipeptide proteins, but upregulated C9orf72 expression","volume":"90","author":"McGoldrick","year":"2018","journal-title":"Neurology"},{"key":"2022011608400581000_92.5.502.46","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddt460"},{"key":"2022011608400581000_92.5.502.47","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-020-0359-8","article-title":"Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers","volume":"15","author":"Jackson","year":"2020","journal-title":"Mol Neurodegener"},{"key":"2022011608400581000_92.5.502.48","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddv064"},{"key":"2022011608400581000_92.5.502.49","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-015-1445-9"},{"key":"2022011608400581000_92.5.502.50","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000317"},{"key":"2022011608400581000_92.5.502.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2018.09.010"},{"key":"2022011608400581000_92.5.502.52","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/jamaneurol.2016.4847","article-title":"Clinical evidence of disease anticipation in families segregating a C9orf72 repeat expansion","volume":"74","author":"Van Mossevelde","year":"2017","journal-title":"JAMA Neurol"},{"key":"2022011608400581000_92.5.502.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2015.04.016"},{"key":"2022011608400581000_92.5.502.54","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/21678421.2016.1262423","article-title":"Sequence variations in C9orf72 downstream of the hexanucleotide repeat region and its effect on repeat-primed PCR interpretation: a large multinational screening study","volume":"18","author":"Nordin","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2022011608400581000_92.5.502.55","doi-asserted-by":"publisher","DOI":"10.1101\/gr.225672.117"},{"key":"2022011608400581000_92.5.502.56","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-1935-5"},{"key":"2022011608400581000_92.5.502.57","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1103-0"},{"key":"2022011608400581000_92.5.502.58","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-6-405"},{"key":"2022011608400581000_92.5.502.59","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0274-4"},{"key":"2022011608400581000_92.5.502.60","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0293-x"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2020-325377","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T11:40:52Z","timestamp":1642333252000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2020-325377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":60,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,4,15]]},"published-print":{"date-parts":[[2021,5]]}},"alternative-id":["10.1136\/jnnp-2020-325377"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2020-325377","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,15]]}}}